Search

Your search keyword '"Xiao-Wu Huang"' showing total 147 results

Search Constraints

Start Over You searched for: Author "Xiao-Wu Huang" Remove constraint Author: "Xiao-Wu Huang"
147 results on '"Xiao-Wu Huang"'

Search Results

1. Neutrophil extracellular traps in central nervous system (CNS) diseases

2. Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

3. Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence

4. Metagenomic Next-Generation Sequencing Versus Traditional Laboratory Methods for the Diagnosis and Treatment of Infection in Liver Transplantation

6. Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine

7. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF‐kB signaling pathways synergistically

8. Circulating microRNAs as a Fingerprint for Liver Cirrhosis.

9. Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.

10. Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis

14. Data from CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma

15. Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

17. Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation

18. Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma

19. Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation

20. TGM3 promotes epithelial–mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection

21. In Situ Normothermic Regional Perfusion for Liver Donation From China Category III (Organ Donation After Brain Death Followed by Circulatory Death): A Single-Center Cohort Study

22. The spatial distribution of immune cell subpopulations in hepatocellular carcinoma

23. Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis

24. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence

25. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma

26. Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria

27. Identification of competing endogenous RNA network in laryngeal squamous cell carcinoma

28. CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma

29. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF‐kB signaling pathways synergistically

30. Enhanced production of short-chain fatty acids from sludge by thermal hydrolysis and acidogenic fermentation for organic resource recovery

31. Adjuvant lenvatinib after radical resection in patients with hepatocellular carcinoma (HCC): Preliminary analysis of a prospective, multi-center, single-arm study

32. Application of circulating tumor DNA for prediction and surveillance of tumor recurrence after liver transplantation: A pilot study

36. Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors

37. A rapid and convenient derivatization method for quantitation of short-chain fatty acids in human feces by ultra-performance liquid chromatography/tandem mass spectrometry

38. A retrospective cohort study of preoperative lipid indices and their impact on new-onset diabetes after liver transplantation

39. Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis

40. Gemox chemotherapy in combination with anti-PD1 antibody toripalimab and lenvatinib as first-line treatment for advanced intrahepatic cholangiocarcinoma: A phase 2 clinical trial

41. Lenvatinib plus toripalimab as first-line treatment for advanced intrahepatic cholangiocarcinoma: A single-arm, phase 2 trial

42. Phase II study of lenvatinib in combination with GEMOX chemotherapy for advanced intrahepatic cholangiocarcinoma

43. Whole-Exome Sequencing-Based Mutational Profiling of Hepatitis B Virus-Related Early-Stage Hepatocellular Carcinoma

44. Donor liver steatosis: A risk factor for early new-onset diabetes after liver transplantation

45. Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection

46. Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial

47. Effect of postoperative apatinib treatment after resection of hepatocellular carcinoma with portal vein invasion: A phase II study

48. A Pharmacogenomic Landscape in Human Liver Cancers

49. 5-Hydroxymethylcytosines from Circulating Cell-free DNA as Diagnostic and Prognostic Markers for Hepatocellular Carcinoma

50. microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A

Catalog

Books, media, physical & digital resources